YESAFILI Trademark

Trademark Overview

On Thursday, August 12, 2021, a trademark application was filed for YESAFILI with the United States Patent and Trademark Office. The USPTO has given the YESAFILI trademark a serial number of 90879797. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, August 20, 2024. This trademark is owned by Mylan Pharmaceuticals Inc.. The YESAFILI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of ophthalmic conditions
yesafili

General Information

Serial Number90879797
Word MarkYESAFILI
Filing DateThursday, August 12, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, August 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment of ophthalmic conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 4, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiosimilars Newco Limited
Party Type22 - New Owner After Publication
Legal Entity Type24 - NOT AVAILABLE
AddressHertfordshire AL109UL
GB
Party NameMYLAN INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCANONSBURG, PA 15317
Party NameMylan Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505
Party NameMylan Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505

Trademark Events

Event DateEvent Description
Monday, August 16, 2021NEW APPLICATION ENTERED
Monday, October 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 18, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 18, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 13, 2022NON-FINAL ACTION WRITTEN
Monday, May 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 12, 2022ASSIGNED TO EXAMINER
Friday, May 13, 2022NON-FINAL ACTION E-MAILED
Friday, May 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 20, 2022ASSIGNED TO LIE
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, December 10, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, December 10, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, December 10, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 15, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 21, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 21, 2023SOU EXTENSION 1 FILED
Monday, March 6, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 22, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 8, 2023SOU EXTENSION 1 GRANTED
Wednesday, June 14, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, March 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 1, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 23, 2024SOU TEAS EXTENSION RECEIVED
Saturday, February 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 1, 2023SOU EXTENSION 2 FILED
Tuesday, August 1, 2023SOU EXTENSION 2 GRANTED
Friday, February 23, 2024SOU EXTENSION 3 FILED
Friday, February 23, 2024SOU EXTENSION 3 GRANTED
Tuesday, August 20, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 20, 2024SOU EXTENSION 4 FILED
Tuesday, August 20, 2024SOU EXTENSION 4 GRANTED

Related Keywords

yesafili ophthalmic conditions treatment human preparations pharmaceutical